番茄社区

Pre-vaccine era data suggest underrecognized burden of disease, especially in older adults

While all adults age 75 and up are eligible, here's who's considered high risk in the 60-74 group

CDC advisors also formalize recommendations on extra COVID vaccine doses in the immunocompromised

However, questions remain about durability of vaccine protection, expert says

Clesrovimab reduced severe disease, hospitalizations in preterm and term healthy infants

The agency has issued a revised fact sheet for healthcare providers

But will benefits seen in Chinese trial translate to clinical improvement?

However, study fails to answer key questions, expert says

Health news and commentary gathered by 番茄社区 staff

Pemivibart may have reduced activity against growing variant KP.3.1.1, agency warns

Many questions remain unanswered due to weak data

Updated COVID vax coming soon, not too early to pre-order vaccines, CDC director says

To some extent, it's to be expected, researchers note

Monoclonal antibody also reduced PICU admissions, need for ventilatory support